Applied InSilico dramatically reduces time and resources during preclinical drug discovery by providing uncompromised insight into complex disease data. Their Evolutionary Learning Environment, ELE(TM), launched today, automates the preclinical drug discovery process by applying non-proprietary, intelligent algorithms within a highly adaptive learning environment.
